Literature DB >> 8017285

Plasma fatty acid levels in infants and adults after myocardial ischemia.

G D Lopaschuk1, R Collins-Nakai, P M Olley, T J Montague, G McNeil, M Gayle, P Penkoske, B A Finegan.   

Abstract

High levels of fatty acids are detrimental during reperfusion of ischemic hearts in part because of an inhibition of myocardial glucose use. We therefore measured plasma fatty acids during and after myocardial ischemia in both adult and pediatric patients. In adult patients undergoing thrombolytic therapy after an acute myocardial infarction, plasma fatty acids levels were elevated on admission to hospital (0.96 +/- 0.06 vs 0.40 +/- 0.01 mmol/L in healthy control subjects) and remained elevated throughout the initial 48 hours of hospitalization. In adult patients undergoing cardiac surgery, plasma fatty acids were markedly increased during surgery and at the time of the release of the aortic cross clamp (2.21 +/- 0.54 and 1.61 +/- 0.32 mmol/L, respectively). In children and infants (mean age 4.33 +/- 0.44 years) who had surgery to correct congenital heart defects, fatty acid levels during surgery increased to 3.27 +/- 0.26 mmol/L and remained elevated during immediate reperfusion (1.91 +/- 0.15 mmol/L) and for 24 hours after surgery (1.67 +/- 0.22 mmol/L). Because experimental studies have shown that high levels of fatty acids are detrimental to recovery of adult animal hearts, we determined the effect of high fatty acid levels on reperfusion recovery of isolated working hearts from 1-day-old rabbits perfused with 0.4 mmol/L palmitate (normal fat) or 1.2 mmol/L palmitate (high fat) and subjected to 50 minutes of global ischemia followed by aerobic reperfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8017285     DOI: 10.1016/0002-8703(94)90010-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  24 in total

1.  Intracellular sodium in the ischemic and reperfused heart and its role in injury.

Authors:  M Bernard; E Cabanes; D Baetz; H El Banani; C Lan; M Izquierdo; P Cozzone; D Feuvray
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.310

Review 2.  Free fatty acid metabolism during myocardial ischemia and reperfusion.

Authors:  S C Hendrickson; J D St Louis; J E Lowe; S Abdel-aleem
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

3.  MicroRNA 375 mediates palmitate-induced enteric neuronal damage and high-fat diet-induced delayed intestinal transit in mice.

Authors:  Behtash Ghazi Nezami; Simon M Mwangi; Jai Eun Lee; Sabrina Jeppsson; Mallappa Anitha; Shadi S Yarandi; Alton B Farris; Shanthi Srinivasan
Journal:  Gastroenterology       Date:  2013-10-25       Impact factor: 22.682

4.  Right Ventricular Remodeling in Hypoplastic Left Heart Syndrome is Minimally Impacted by Cardiopulmonary Bypass: A Comparison of Norwood vs. Hybrid.

Authors:  Kandice Mah; Jesus Serrano Lomelin; Timothy Colen; Edythe B Tham; Lily Lin; Luke Eckersley; Jeffrey F Smallhorn; Harald Becher; Luc Mertens; Nee Scze Khoo
Journal:  Pediatr Cardiol       Date:  2020-10-10       Impact factor: 1.655

Review 5.  Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.

Authors:  Andrew A Wolff; Heschi H Rotmensch; William C Stanley; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

6.  Differential effects of AMP-activated protein kinase in isolated rat atria subjected to simulated ischemia-reperfusion depending on the energetic substrates available.

Authors:  Romina Hermann; Victoria Evangelina Mestre Cordero; María de Las Mercedes Fernández Pazos; Federico Joaquín Reznik; Débora Elisabet Vélez; Enrique Alberto Savino; María Gabriela Marina Prendes; Alicia Varela
Journal:  Pflugers Arch       Date:  2017-10-14       Impact factor: 3.657

Review 7.  Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis.

Authors:  Clifford D L Folmes; Alexander S Clanachan; Gary D Lopaschuk
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113

8.  Impact of lactate in the perfusate on function and metabolic parameters of isolated working rat heart.

Authors:  Arzu Onay-Besikci
Journal:  Mol Cell Biochem       Date:  2006-09-06       Impact factor: 3.396

9.  Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1α and upregulation of peroxisome proliferator-activated receptor-α.

Authors:  Shouji Matsushima; Junya Kuroda; Tetsuro Ago; Peiyong Zhai; Yoshiyuki Ikeda; Shinichi Oka; Guo-Hua Fong; Rong Tian; Junichi Sadoshima
Journal:  Circ Res       Date:  2013-03-08       Impact factor: 17.367

Review 10.  AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease.

Authors:  Aaron K F Wong; Jacqueline Howie; John R Petrie; Chim C Lang
Journal:  Clin Sci (Lond)       Date:  2009-04       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.